Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07083557 · ClinicalTrials.gov registry record

Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)

A clinical trial of Heart Failure and Diabetes, sponsored by Bettina Mittendorfer.

Recruiting
Registry status
100
Enrollment target
1
Study location

NCT07083557: Recruiting study of Heart Failure and Diabetes, sponsored by Bettina Mittendorfer.

NCT07083557 is a study of Heart Failure and Diabetes that is actively recruiting participants, run by Bettina Mittendorfer. The registered enrollment target is 100 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07083557, a study of Heart Failure and Diabetes, is actively recruiting participants, sponsored by Bettina Mittendorfer.

RECRUITING
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to validate (check the accuracy of) laboratory assays, intravenous catheter insertion, and equipment or devices and their reproducibility, which is necessary to perform high quality research on chronic diseases, nutrition, and metabolism (the process by which a substance is handled in the body) at the University of Missouri. As technology changes and uses new testing methods, it is necessary to compare results from old tests, equipment and devices and new tests, equipment, or devices and the reproducibility of these measurements to make sure the results are accurate. Reproducibility means performing the same test more than once to see if the same results can be achieved each time. This study will look at the validation and reproducibility of tests and laboratory assays in participants who are healthy or affected by relevant endocrine, cardiometabolic, and musculoskeletal disorders.

Primary Outcome

Comparison of insulin results across assays (methods of measuring) to evaluate the validity and reproducibility in the basic science laboratory environment across healthy and disordered populations

Interventions

  • OTHER Endothelial cell collection

Study Locations (1)

Missouri

  • University of Missouri-Columbia - Columbia

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2026-01-01
Est. Completion 2030-07-01
Bettina Mittendorfer

4 total trials

What NCT07083557 shows while recruiting

NCT07083557 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (95% lower).

The record links to 10 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Endothelial cell collection is the first listed.

NCT07083557 reports a single indexed study location in Missouri.

Frequently Asked Questions

What is clinical trial NCT07083557 about?

NCT07083557 is a clinical study titled "Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)". The purpose of this research study is to validate (check the accuracy of) laboratory assays, intravenous catheter insertion, and equipment or devices and their reproducibility, which is necessary to perform high quality research on chronic diseases, nutrition, and metabolism (the process by which a ...

What is the current status of trial NCT07083557?

This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2026-01-01. Estimated completion is 2030-07-01.

What conditions does trial NCT07083557 study?

This clinical trial studies the following conditions: Heart Failure, Diabetes, Osteoporosis, Sarcopenia, Ischemic Heart Disease.

What interventions are being tested in trial NCT07083557?

The interventions under investigation include: Endothelial cell collection (OTHER).

Who is sponsoring clinical trial NCT07083557?

This trial is sponsored by Bettina Mittendorfer, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07083557 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07083557's enrollment target sits among peer trials

100 212th of 397 higher than 177 of 397 other Heart Failure trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07083557, the US trial registry maintained by the National Library of Medicine. NCT07083557 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.